NORTHERN ILLINOIS CANCER TREATMENT CENTER (EIN 363572331) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1988

Legal Domicile

Principal Officer

DIRK MEMINGER

Phone

8152841111

Tax Period

2024-05-01 to 2025-04-30

NORTHERN ILLINOIS CANCER TREATMENT CENTER, founded in 1988, is a community nonprofit in the Diseases & Disorders sector that reported $2.9M in total revenue in fiscal year 2024. Revenue decreased 7% compared to the prior year. Expenses of $3.7M exceeded revenue, resulting in a 28% operating deficit.

Mission

OPERATE A CANCER CENTER WITH HIGHLY SOPHISTICATED DIAGNOSTIC AND TREATMENT PROCEDURES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,078

Program Service Revenue $2,880,409

Investment Income $-4,556

Other Revenue $1,720

TOTAL REVENUE $2,878,651

Expense Breakdown

Grants Paid $16,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $3,526,268

Other Expenses $3,670,138

TOTAL EXPENSES $3,686,138

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,878,651	$3,099,633	-0.1%
Expenses	$3,686,138	$3,634,040	+0.0%
Net Income	$-807,487	$-534,407	+0.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DIRK MEMINGER	PRESIDENT	40.00	Officer Director	$0	$0	$0
CINDY ZANDER	TREASURER	4.00	Officer Director	$0	$0	$0
AJ QUERCIAGROSSA	SECRETARY	4.00	Officer Director	$0	$0	$0
MICHAEL HEFTY MD	MEMBER	2.00	Director	$0	$0	$0
COLLEEN HENKEL	MEMBER	2.00	Director	$0	$0	$0
YOUNG SONG DO	MEMBER	2.00	Director	$0	$0	$0
HEATHER SOTELO	MEMBER	2.00	Director	$0	$0	$0
SHERI NELSON	INTERIM EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,878,651	$3,686,138	$5,690,817	$-807,487
2024	$3,099,633	$3,634,040	$6,356,642	$-534,407
2023	$3,300,407	$3,348,767	$6,881,428	$-48,360
2022	$2,837,443	$3,090,892	$6,957,137	$-253,449
2021	$2,005,633	$2,739,592	$7,200,168	$-733,959
2020	$2,850,770	$2,763,163	$7,903,295	$87,607
2019	$2,328,699	$2,643,567	$7,720,345	$-314,868

NORTHERN ILLINOIS CANCER TREATMENT CENTER